Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Inventiva SA

IVA.PA ✓ COMPLIANT ☆ Track — members

Euronext Paris · Healthcare · Biotechnology & Medical Research ·

France Small Cap Analyst: STRONG BUY

Last Close

$4.77

▲ +3.29%

Market Cap $1.13B · Vol 279.41K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$1.13B

Small Cap

Div Yield

N/A

Annual dividend

EPS Growth

+65.08%

YoY

RSI (14)

56.52

Momentum

Beta

0.37

vs Market

52W High

$7.24

35.02% below

52W Low

$3.36

45.47% above

Volume

279.41K

Avg 303.13K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

71.62%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Inventiva SA (IVA.PA) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does IVA.PA pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+4.34%

+6.94%

-11.87%

-29.45%

YTD

+3.55%

+1.36%

+34.62%

-59.23%

Financials & Valuation

TTM · Annual

Total Revenue	$5.27M
Net Income	$-415,520,947.00
Revenue Growth (YoY)	-99.68%
Gross Margin	100.00%
Operating Margin	-2,957.28%
Net Profit Margin	-7,899.55%
ROE	N/A
ROA · ROIC	-192.01% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	164.38
P/B	N/A
P/FCF	N/A
EPS Growth	+65.08%
Outstanding Shares	236.28M

Technical Indicators

50-Day SMA	$4.31
200-Day SMA	$5.03
RSI (14)	56.52
Beta	0.37
52-Week High	$7.24
52-Week Low	$3.36

Volume Today	279.41K
Avg Daily Volume (30D)	303.13K
Relative Volume	0.92x
Volatility (10D)	47.25
Volatility (30D)	41.03
Free Float	71.62%

Analyst Consensus

STRONG BUY

Current Price $4.77

Mean Target $13.89

52W Low$3.36 52W High$7.24

Current

Target

$3.36 $7.24

Current Analyst target

+191.31% upside potential · 10 analysts

Identifiers

ExchangeEuronext Paris

FIGIBBG00VM4C3W3

ISINFR0013233012

CountryFrance

Sub-IndustryBio Therapeutic Drugs

Earnings DateSep 25, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

2359.HK WuXi AppTec Co Ltd +3.29% ARGX.BR argenx SE +1.74% ARGX argenx SE +0.83% 2269.HK WuXi Biologics (Cayman) Inc +7.41% INSM Insmed Inc -0.07%

Company Profile

Inventiva SA is a France-based company engaged in the biotechnology sector. The Company focuses on the development of therapies in the area of oncology, fibrosis and rare diseases. The Company’s pipeline comprises a number of development programs, such as Clinical Pipeline, Preclinical Pipeline, AbbVie Collaboration and Boehringer-Ingelheim collaboration. Its drug candidates target at the treatment of non-alcoholic steatohepatitis (NASH), systemic sclerosis (SSc), various types of mucopolysaccharidosis (MPS), multiple myeloma, auto-immune disorders, as well as lung cancer, among others. In addition, the Company offers drug discovery services, ranging from target identification to preclinical nomination, in numerous areas, such as silico modelling, biology, screening, absorption, distribution, metabolism and excretion (ADME), pharmacology and histology.